Digital Therapeutics

About iWel

iWel Health is a private, pre-revenue biotech/digital health company founded in 2016, focusing on making CGM technology accessible for wellness and metabolic health management. The company is developing a disposable, smartphone-connected CGM device aimed at the large markets of weight loss (including GLP-1 users), prediabetes, and diabetes. Led by a seasoned medical device and pharmaceutical veteran, iWel is positioning itself in the competitive CGM landscape by emphasizing affordability and over-the-counter accessibility for non-traditional, consumer-led use cases.

About Otsuka Holdings

Otsuka Holdings is a multinational healthcare leader founded on the mission 'Otsuka-people creating new products for better health worldwide.' It has achieved global prominence through flagship CNS drugs, a strategic stake in Lundbeck, and blockbuster nutraceutical brands like Pocari Sweat. The company's strategy is built on a diversified four-pillar business model—pharmaceuticals, nutraceuticals, medical devices, and chemicals—driven by a unique culture of creativity ('Souzoususei') and evidence-based validation ('Jisshou').

Therapeutic Areas